CASI Pharmaceuticals Inc (CASI)
5.74
+0.19
(+3.42%)
USD |
NASDAQ |
Nov 14, 16:00
5.46
-0.28
(-4.88%)
After-Hours: 18:08
CASI Pharmaceuticals Shareholders Equity (Quarterly): 9.021M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 9.021M |
March 31, 2024 | 15.47M |
December 31, 2023 | 24.16M |
September 30, 2023 | 28.79M |
June 30, 2023 | 32.23M |
March 31, 2023 | 39.58M |
December 31, 2022 | 44.57M |
September 30, 2022 | 61.71M |
June 30, 2022 | 66.94M |
March 31, 2022 | 74.99M |
December 31, 2021 | 84.50M |
September 30, 2021 | 86.61M |
June 30, 2021 | 94.80M |
March 31, 2021 | 100.03M |
December 31, 2020 | 81.54M |
September 30, 2020 | 91.53M |
June 30, 2020 | 63.34M |
March 31, 2020 | 70.36M |
December 31, 2019 | 73.00M |
September 30, 2019 | 80.37M |
June 30, 2019 | 89.04M |
March 31, 2019 | 104.20M |
December 31, 2018 | 109.46M |
September 30, 2018 | 113.32M |
June 30, 2018 | 83.52M |
Date | Value |
---|---|
March 31, 2018 | 67.62M |
December 31, 2017 | 38.54M |
September 30, 2017 | 15.58M |
June 30, 2017 | 17.03M |
March 31, 2017 | 19.24M |
December 31, 2016 | 20.78M |
September 30, 2016 | 16.02M |
June 30, 2016 | 10.02M |
March 31, 2016 | 4.637M |
December 31, 2015 | -6.087M |
September 30, 2015 | -4.732M |
June 30, 2015 | -3.449M |
March 31, 2015 | -1.826M |
December 31, 2014 | -0.4222M |
September 30, 2014 | 0.8377M |
June 30, 2014 | 12.74M |
March 31, 2014 | 13.86M |
December 31, 2013 | 14.94M |
September 30, 2013 | 15.76M |
June 30, 2013 | 16.79M |
March 31, 2013 | 17.69M |
December 31, 2012 | 8.235M |
September 30, 2012 | 8.364M |
June 30, 2012 | 9.290M |
March 31, 2012 | 2.420M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
9.021M
Minimum
Jun 2024
100.03M
Maximum
Mar 2021
60.17M
Average
66.94M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
Sinovac Biotech Ltd | 8.649B |
Zai Lab Ltd | 704.18M |
China SXT Pharmaceuticals Inc | 13.93M |
Adagene Inc | 56.59M |
LakeShore Biopharma Co Ltd | 76.35M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 51.27M |
Total Liabilities (Quarterly) | 42.25M |
Debt to Equity Ratio | 2.047 |
Current Ratio | 3.882 |
Net Debt Paydown Yield | -4.65% |